SCHEMBL7988660

SCHEMBL7988660

CCCc1nc(O)c2c(ncn2Cc2cccc(C)c2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.49
CYP11B2 P19099 3/20 0.49
ALDH1A1 P00352 2/20 0.49
LMNA P02545 2/20 0.41
HPGD P15428 5/20 0.40
TSHR P16473 4/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
ALOX15 P16050 1/20 0.38
MMP13 P45452 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
RECQL P46063 1/20 0.37
MAPT P10636 3/20 0.37
POLB P06746 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974260 0.92 CYP11B1 (0.47) CYP11B1CYP11B2ALDH1A1LMNAHPGD
SCHEMBL7992186 0.91 CYP11B1 (0.47) CYP11B1CYP11B2ALDH1A1LMNAHPGD
SCHEMBL7988484 0.87 PDE1A (0.43) CYP11B1CYP11B2ALDH1A1LMNAHPGD
SCHEMBL7991724 0.87 SMN1; SMN2 (0.47) HTTSMN1; SMN2ADORA2AADORA1MMP13
SCHEMBL7989407 0.87 HPGD (0.44) CYP11B1CYP11B2ALDH1A1HPGDTSHR
SCHEMBL7988356 0.86 ALDH1A1 (0.44) CYP11B1CYP11B2ALDH1A1LMNAHPGD
SCHEMBL7989377 0.85 LMNA (0.44) CYP11B1CYP11B2ALDH1A1LMNAHPGD
SCHEMBL7984135 0.85 GAA (0.49) ALDH1A1LMNASMN1; SMN2ADORA2AADORA1
SCHEMBL7985861 0.81 CNOT7 (0.44) CYP11B1ALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL7987609 0.81 PDE4A (0.43) CYP11B1CYP11B2ALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed